Immaculé

As we remain dedicated to innovation, quality and delivering advanced healthcare solutions, we are expanding our product manufacturing capabilities. With an investment of USD 100 million, this expansion is scheduled for completion by May 2024 and will cater to the diverse needs of the industry. Through this expansion we will bring in a new Freeze-Drying capacity, Ophthalmic capacity, Pre-Filled Syringe and Cartridge capacity as well as mark our entry into the production of oncology injectables.